HORVATH SUSAN (V.P. of Finance & CFO) purchased 22.0% of their position (2.42K shares) of PANBELA THERAPEUTICS, INC. on the open market
Open‑market purchases signal personal conviction — classified as a significant purchase.
P · 1 purchase
Filed: 9/1/2020ACC: 0001437749-20-019145
Officer· V.P. of Finance & CFO
Since Dec 2018
+4.85K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
4.85K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.42K
Price / share
—
Trade value
—
% of position
22.0%
9/1/2020
11.01K→13.44K
Total
Net shares
+2.42K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2020 | P · Purchase | +2.42K | — | — | 22.0% | 11.01K | 13.44K |
| Total | +2.42K | $0.00 | ||||||
Derivative Transactions1
Warrant (right to buy)
Direct
Converts to
Common Stock
2.42K shares
Shares
+2.42K
Strike price
4.54
Held after
2.42K
Exercisable
—
9/1/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common Stock2.42K shares | 9/1/2020 | P · Purchase | +2.42K | 4.54 | — | 2.42K |